Evaluating the Market Potential of New Radiopharmaceutical Therapies
Time: 3:00 pm
day: Conference Day Two
Details:
- Assess the commercial viability of isotopes like copper-67, and lead-212
- Explore investment trends and venture capital funding in CDMOs to diversify product offerings
- Identify strategic partnerships and licensing opportunities to secure sustainable supply chains for new therapies
